Abstract
Background
Gastric cancer and liver cirrhosis (LC) are often comorbid. However, little is known about the clinical outcomes of gastric endoscopic submucosal dissection (ESD) in patients with comorbid LC.
Methods
This case–control study used a multicentre retrospective cohort. We identified 69 LC patients from the cohort of patients with early gastric cancer, who underwent gastric ESD at 12 hospitals from March 2003 to November 2010. Using the propensity score matching method, 69 patients without LC were used to compare the short- and long-term outcomes of ESD.
Results
Among the 69 LC patients, 53 (77 %) were Child-Pugh grade A (CP-A) and 16 (28 %) had past or present histories of hepatocellular carcinoma (HCC). Short-term outcomes did not differ between the LC patients and controls or between the CP-A and CP-B/C patients. Although the LC patients had significantly worse long-term outcomes than the controls (the 5-year overall survival rates were 60 vs. 91 %, respectively), patients with CP-A liver function without HCC histories had an overall survival almost equivalent to that of patients without LC (controls).
Conclusions
LC patients appear to be good candidates for ESD if they have CP-A liver function and no history of HCC. Although their short-term outcomes were not inferior, the patients with Child-Pugh grades B/C or with histories of HCC benefited less from ESD.
Similar content being viewed by others
Abbreviations
- EGC:
-
Early gastric cancer
- ER:
-
Endoscopic resection
- QOL:
-
Quality of life
- EMR:
-
Endoscopic mucosal resection
- ESD:
-
Endoscopic submucosal dissection
References
Organization WH (2008) World cancer report. IARC Press, Lyon
Fock KM, Talley N, Moayyedi P, Hunt R, Azuma T, Sugano K, Xiao SD, Lam SK, Goh KL, Chiba T, Uemura N, Kim JG, Kim N, Ang TL, Mahachai V, Mitchell H, Rani AA, Liou JM, Vilaichone RK, Sollano J (2008) Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 23(3):351–365. doi:10.1111/j.1440-1746.2008.05314.x
Zaterka S, Eisig JN, Chinzon D, Rothstein W (2007) Factors related to Helicobacter pylori prevalence in an adult population in Brazil. Helicobacter 12(1):82–88. doi:10.1111/j.1523-5378.2007.00474.x
Robinson LG, Black FL, Lee FK, Sousa AO, Owens M, Danielsson D, Nahmias AJ, Gold BD (2002) Helicobacter pylori prevalence among indigenous peoples of South America. J Infect Dis 186(8):1131–1137. doi:10.1086/343803
Azevedo NF, Huntington J, Goodman KJ (2009) The epidemiology of Helicobacter pylori and public health implications. Helicobacter 14(Suppl 1):1–7. doi:10.1111/j.1523-5378.2009.00703.x
Ford AC, Axon AT (2010) Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 15(Suppl 1):1–6. doi:10.1111/j.1523-5378.2010.00779.x
Goh KL, Chan WK, Shiota S, Yamaoka Y (2011) Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 16(Suppl 1):1–9. doi:10.1111/j.1523-5378.2011.00874.x
Sano T, Kobori O, Muto T (1992) Lymph node metastasis from early gastric cancer: endoscopic resection of tumour. Br J Surg 79(3):241–244
Shimizu S, Tada M, Kawai K (1995) Early gastric cancer: its surveillance and natural course. Endoscopy 27(1):27–31. doi:10.1055/s-2007-1005628
Isomoto H, Shikuwa S, Yamaguchi N, Fukuda E, Ikeda K, Nishiyama H, Ohnita K, Mizuta Y, Shiozawa J, Kohno S (2009) Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut 58(3):331–336. doi:10.1136/gut.2008.165381
Goto O, Fujishiro M, Kodashima S, Ono S, Omata M (2009) Outcomes of endoscopic submucosal dissection for early gastric cancer with special reference to validation for curability criteria. Endoscopy 41(2):118–122. doi:10.1055/s-0028-1119452
Akasaka T, Nishida T, Tsutsui S, Michida T, Yamada T, Ogiyama H, Kitamura S, Ichiba M, Komori M, Nishiyama O, Nakanishi F, Zushi S, Nishihara A, Iijima H, Tsujii M, Hayashi N (2011) Short-term outcomes of endoscopic submucosal dissection (ESD) for early gastric neoplasm: multicenter survey by osaka university ESD study group. Dig Endosc 23(1):73–77. doi:10.1111/j.1443-1661.2010.01062.x
Kato M, Nishida T, Tsutsui S, Komori M, Michida T, Yamamoto K, Kawai N, Kitamura S, Zushi S, Nishihara A, Nakanishi F, Kinoshita K, Yamada T, Iijima H, Tsujii M, Hayashi N (2011) Endoscopic submucosal dissection as a treatment for gastric noninvasive neoplasia: a multicenter study by Osaka University ESD Study Group. J Gastroenterol 46(3):325–331. doi:10.1007/s00535-010-0350-1
Chung IK, Lee JH, Lee SH, Kim SJ, Cho JY, Cho WY, Hwangbo Y, Keum BR, Park JJ, Chun HJ, Kim HJ, Kim JJ, Ji SR, Seol SY (2009) Therapeutic outcomes in 1,000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study. Gastrointest Endosc 69(7):1228–1235. doi:10.1016/j.gie.2008.09.027
Kato M, Nishida T, Yamamoto K, Hayashi S, Kitamura S, Yabuta T, Yoshio T, Nakamura T, Komori M, Kawai N, Nishihara A, Nakanishi F, Nakahara M, Ogiyama H, Kinoshita K, Yamada T, Iijima H, Tsujii M, Takehara T (2012) Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group. Gut 62(10):1425–1432. doi:10.1136/gutjnl-2011-301647
El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142(6):1264–1273. doi:10.1053/j.gastro.2011.12.061 e1261
Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60(8):646–649
Ogura K, Okamoto M, Sugimoto T, Yahagi N, Fujishiro M, Kakushima N, Kodashima S, Kawabe T, Omata M (2008) Efficacy and safety of endoscopic submucosal dissection for gastric cancer in patients with liver cirrhosis. Endoscopy 40(5):443–445
D’Agostino RB Jr (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17(19):2265–2281
Nishida T, Tsuji S, Tsujii M, Arimitsu S, Haruna Y, Imano E, Suzuki M, Kanda T, Kawano S, Hiramatsu N, Hayashi N, Hori M (2006) Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis. Am J Gastroenterol 101(1):70–75. doi:10.1111/j.1572-0241.2005.00307.x
Ikeda Y, Kanda T, Kosugi S, Yajima K, Matsuki A, Suzuki T, Hatakeyama K (2009) Gastric cancer surgery for patients with liver cirrhosis. World J Gastrointest Surg 1(1):49–55. doi:10.4240/wjgs.v1.i1.49
Jang HJ, Kim JH, Song HH, Woo KH, Kim M, Kae SH, Lee J, Cho JW, Kang JH, Lee SI, Gong SJ, Lee JA, Zang DY (2008) Clinical outcomes of patients with liver cirrhosis who underwent curative surgery for gastric cancer: a retrospective multi-center study. Dig Dis Sci 53(2):399–404. doi:10.1007/s10620-007-9884-3
Lee JH, Kim J, Cheong JH, Hyung WJ, Choi SH, Noh SH (2005) Gastric cancer surgery in cirrhotic patients: result of gastrectomy with D2 lymph node dissection. World J Gastroenterol 11(30):4623–4627
Ryu KW, Lee JH, Kim YW, Park JW, Bae JM (2005) Management of ascites after radical surgery in gastric cancer patients with liver cirrhosis and minimal hepatic dysfunction. World J Surg 29(5):653–656. doi:10.1007/s00268-005-7715-2
Isozaki H, Okajima K, Ichinona T, Fujii K, Nomura E, Izumi N (1997) Surgery for gastric cancer in patients with cirrhosis. Surg Today 27(1):17–21
Takeda J, Hashimoto K, Tanaka T, Koufuji K, Kakegawa T (1992) Review of operative indication and prognosis in gastric cancer with hepatic cirrhosis. Hepatogastroenterology 39(5):433–436
Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, Kato Y (2000) Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 3(4):219–225
Verrill C, Markham H, Templeton A, Carr NJ, Sheron N (2009) Alcohol-related cirrhosis—early abstinence is a key factor in prognosis, even in the most severe cases. Addiction 104(5):768–774. doi:10.1111/j.1360-0443.2009.02521.x
Hu KQ, Tong MJ (1999) The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States. Hepatology 29(4):1311–1316. doi:10.1002/hep.510290424
Disclosure
Drs. Kato, Nishida, Hamasaki, Kawai, Yoshio, Egawa, Yamamoto, Ogiyama, Komori, Nakahara, Yabuta, Nishihara, Yamaguchi, Yamada, Hayashi, Iijima, Michida, Tsujii, and Takehara have no conflicts of interest or financial ties to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kato, M., Nishida, T., Hamasaki, T. et al. Outcomes of ESD for patients with early gastric cancer and comorbid liver cirrhosis: a propensity score analysis. Surg Endosc 29, 1560–1566 (2015). https://doi.org/10.1007/s00464-014-3841-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-014-3841-y